224 related articles for article (PubMed ID: 28548932)
1. LncRNA TINCR attenuates cardiac hypertrophy by epigenetically silencing CaMKII.
Shao M; Chen G; Lv F; Liu Y; Tian H; Tao R; Jiang R; Zhang W; Zhuo C
Oncotarget; 2017 Jul; 8(29):47565-47573. PubMed ID: 28548932
[TBL] [Abstract][Full Text] [Related]
2. Cardiac-specific BACH1 ablation attenuates pathological cardiac hypertrophy by inhibiting the Ang II type 1 receptor expression and the Ca2+/CaMKII pathway.
Wei X; Jin J; Wu J; He Y; Guo J; Yang Z; Chen L; Hu K; Li L; Jia M; Li Q; Lv X; Ge F; Ma S; Wu H; Zhi X; Wang X; Jiang L; Osto E; Zhang J; Meng D
Cardiovasc Res; 2023 Aug; 119(9):1842-1855. PubMed ID: 37279500
[TBL] [Abstract][Full Text] [Related]
3. LncRNA Tincr regulates PKCɛ expression in a miR-31-5p-dependent manner in cardiomyocyte hypertrophy.
Li H; Shi H; Zhang F; Xue H; Wang L; Tian J; Xu J; Han Q
Naunyn Schmiedebergs Arch Pharmacol; 2020 Dec; 393(12):2495-2506. PubMed ID: 32157348
[TBL] [Abstract][Full Text] [Related]
4. The H19 long noncoding RNA is a novel negative regulator of cardiomyocyte hypertrophy.
Liu L; An X; Li Z; Song Y; Li L; Zuo S; Liu N; Yang G; Wang H; Cheng X; Zhang Y; Yang X; Wang J
Cardiovasc Res; 2016 Jul; 111(1):56-65. PubMed ID: 27084844
[TBL] [Abstract][Full Text] [Related]
5. LncRNA TINCR improves cardiac hypertrophy by regulating the miR-211-3p-VEGFB-SDF-1α-CXCR4 pathway.
Tu S; Wang XY; Zeng LX; Shen ZJ; Zhang ZH
Lab Invest; 2022 Mar; 102(3):253-262. PubMed ID: 34732848
[TBL] [Abstract][Full Text] [Related]
6. Type III Transforming Growth Factor-β Receptor Drives Cardiac Hypertrophy Through β-Arrestin2-Dependent Activation of Calmodulin-Dependent Protein Kinase II.
Lou J; Zhao D; Zhang LL; Song SY; Li YC; Sun F; Ding XQ; Yu CJ; Li YY; Liu MT; Dong CJ; Ji Y; Li H; Chu W; Zhang ZR
Hypertension; 2016 Sep; 68(3):654-66. PubMed ID: 27432858
[TBL] [Abstract][Full Text] [Related]
7. The combined inhibition of the CaMKIIδ and calcineurin signaling cascade attenuates IGF-IIR-induced cardiac hypertrophy.
Chen CH; Lin JW; Huang CY; Yeh YL; Shen CY; Badrealam KF; Ho TJ; Padma VV; Kuo WW; Huang CY
J Cell Physiol; 2020 Apr; 235(4):3539-3547. PubMed ID: 31584202
[TBL] [Abstract][Full Text] [Related]
8. Long Noncoding RNA
Yu J; Yang Y; Xu Z; Lan C; Chen C; Li C; Chen Z; Yu C; Xia X; Liao Q; Jose PA; Zeng C; Wu G
Circ Heart Fail; 2020 Jan; 13(1):e006525. PubMed ID: 31957467
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of lncRNA Gm15834 Attenuates Autophagy-Mediated Myocardial Hypertrophy via the miR-30b-3p/ULK1 Axis in Mice.
Song C; Qi H; Liu Y; Chen Y; Shi P; Zhang S; Ren J; Wang L; Cao Y; Sun H
Mol Ther; 2021 Mar; 29(3):1120-1137. PubMed ID: 33130312
[TBL] [Abstract][Full Text] [Related]
10. The long noncoding RNA CHRF regulates cardiac hypertrophy by targeting miR-489.
Wang K; Liu F; Zhou LY; Long B; Yuan SM; Wang Y; Liu CY; Sun T; Zhang XJ; Li PF
Circ Res; 2014 Apr; 114(9):1377-88. PubMed ID: 24557880
[TBL] [Abstract][Full Text] [Related]
11. MiR-625-5p Inhibits Cardiac Hypertrophy Through Targeting STAT3 and CaMKII.
Cai K; Chen H
Hum Gene Ther Clin Dev; 2019 Dec; 30(4):182-191. PubMed ID: 31617427
[TBL] [Abstract][Full Text] [Related]
12. Ablation of lncRNA
Yang L; Deng J; Ma W; Qiao A; Xu S; Yu Y; Boriboun C; Kang X; Han D; Ernst P; Zhou L; Shi J; Zhang E; Li TS; Qiu H; Nakagawa S; Blackshaw S; Zhang J; Qin G
Theranostics; 2021; 11(16):7995-8007. PubMed ID: 34335976
[No Abstract] [Full Text] [Related]
13. Transcribed Ultraconserved Regions, Uc.323, Ameliorates Cardiac Hypertrophy by Regulating the Transcription of CPT1b (Carnitine Palmitoyl transferase 1b).
Sun Y; Fan W; Xue R; Dong B; Liang Z; Chen C; Li J; Wang Y; Zhao J; Huang H; Jiang J; Wu Z; Dai G; Fang R; Yan Y; Yang T; Huang ZP; Dong Y; Liu C
Hypertension; 2020 Jan; 75(1):79-90. PubMed ID: 31735087
[TBL] [Abstract][Full Text] [Related]
14. Sp1-induced LncRNA CTBP1-AS2 is a novel regulator in cardiomyocyte hypertrophy by interacting with FUS to stabilize TLR4.
Luo X; He S; Hu Y; Liu J; Chen X
Cardiovasc Pathol; 2019; 42():21-29. PubMed ID: 31220774
[TBL] [Abstract][Full Text] [Related]
15. Cardiac hypertrophy is positively regulated by long non-coding RNA PVT1.
Yu YH; Hu ZY; Li MH; Li B; Wang ZM; Chen SL
Int J Clin Exp Pathol; 2015; 8(3):2582-9. PubMed ID: 26045764
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA KCND1 protects hearts from hypertrophy by targeting YBX1.
Yang R; Li L; Hou Y; Li Y; Zhang J; Yang N; Zhang Y; Ji W; Yu T; Lv L; Liang H; Li X; Li T; Shan H
Cell Death Dis; 2023 May; 14(5):344. PubMed ID: 37253771
[TBL] [Abstract][Full Text] [Related]
17. LncRNA TINCR is downregulated in diabetic cardiomyopathy and relates to cardiomyocyte apoptosis.
Chen Y; Tan S; Liu M; Li J
Scand Cardiovasc J; 2018 Dec; 52(6):335-339. PubMed ID: 30453794
[TBL] [Abstract][Full Text] [Related]
18. Role of serotonin 5-HT2A receptors in the development of cardiac hypertrophy in response to aortic constriction in mice.
Lairez O; Cognet T; Schaak S; Calise D; Guilbeau-Frugier C; Parini A; Mialet-Perez J
J Neural Transm (Vienna); 2013 Jun; 120(6):927-35. PubMed ID: 23543114
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of PEP-19 suppresses angiotensin II-induced cardiomyocyte hypertrophy.
Xie YY; Sun MM; Lou XF; Zhang C; Han F; Zhang BY; Wang P; Lu YM
J Pharmacol Sci; 2014; 125(3):274-82. PubMed ID: 25048017
[TBL] [Abstract][Full Text] [Related]
20. STAT3-induced upregulation of lncRNA MEG3 regulates the growth of cardiac hypertrophy through miR-361-5p/HDAC9 axis.
Zhang J; Liang Y; Huang X; Guo X; Liu Y; Zhong J; Yuan J
Sci Rep; 2019 Jan; 9(1):460. PubMed ID: 30679521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
